Results 271 to 280 of about 255,378 (313)

Mammalian target of rapamycin

Seminars in Oncology, 2004
Targeted molecular therapeutics are tailored toward the genetic abnormalities that cause tumor progression. Modulation of certain signaling pathways that are aberrant in cancer cells has the potential to provide an effective, nontoxic approach to therapy in a broad range of cancers. Agents targeting BCR-ABL (imatinib mesylate [formerly known as STI-571]
Funda, Meric-Bernstam, Gordon B, Mills
openaire   +2 more sources

Rapamycin in Lung Transplantation

Transplantation Proceedings, 2005
Rapamycin (RAPA) is a powerful immunosuppressant that also acts as an antiproliferative, which, therefore, could be useful in the treatment and prevention of bronchiolitis obliterans (BOS) in lung transplant recipients. We sought to report our experiences with RAPA in lung transplant patients with BOS that has not responded to the administration of ...
R Laporta, Hernández, P Ussetti, Gil, C García, Gallo, A, de Pablo Gafas, M C Carreño, Hernández, M J Ferreiro, Alvarez   +5 more
openaire   +2 more sources

Rapamycin: Therapeutic range investigations

Clinical Biochemistry, 1993
R Yatscoff, N Kneteman, J Fryer
openaire   +1 more source

Nutritional reprogramming of mouse liver proteome is dampened by metformin, resveratrol, and rapamycin

Cell Metabolism, 2021
Samantha M Solon-Biet, Benjamin Leo Parker, Nicholas J Hunt   +2 more
exaly  

Rapamycin

Drugs of the Future, 1977
openaire   +1 more source

Rapamycin

2006
openaire   +2 more sources

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability

Nature Nanotechnology, 2022
Jacqueline A Burke, Sharan Bobbala, Sean D Allen   +2 more
exaly  

Rapamycin

2010
Stan Floresco, Robert Kessler, Ronald L. Cowan, Robert Kessler, Ronald L. Cowan, Mark Slifstein, Andrea Cipriani, John Geddes, Tooru M. Mizuno, Seithikurippu R. Pandi-Perumal, Milton Kramer, Michael J. Thorpy, Shelby Freedman Harris, D. Warren Spence, Harriet de Wit, Galen R. Wenger, David V. Sheehan, Kathy H. Sheehan, Peter Riederer, Siegfried Hoyer, Klaus A. Miczek, Christoph Hiemke, Luis Stinus, Stéphanie Caillé, Martine Cador, Susan Jones, Josee E. Leysen, Xavier Langlois, Lieve Heylen, Adriaan A. Lammertsma, Hilde Lavreysen, John Atack, Arthur Christopoulos, Gregory D. Stewart, Patrick M. Sexton, Iván Izquierdo, Lia R. Bevilaqua, Martin Cammarota, Lukas Pezawas, Francis C. Colpaert, Mischa de Rover, Sander Nieuwenhuis, Sarah H. Heil, Stacey C. Sigmon, Stephen T. Higgins, Roy Wise, Paul B. S. Clarke, Mary E. Cain, Michael T. Bardo, Sunila G. Nair, Yavin Shaham, Yavin Shaham, John R. Mantsch, Alan J. Budney, David S. Baldwin, Ashwini Padhi, Naomi A. Fineberg, Helen J. Cassaday, Michael M. Morgan, MacDonald J. Christie, Seithikurippu R. Pandi-Perumal, Milton Kramer, Michael J. Thorpy, Shelby Freedman Harris, D. Warren Spence, Stephen M. Stahl, Meghan M. Grady, Stephen M. Stahl, Warren H. Meck, Catalin V. Buhusi, Thomas Steckler, Ennio Esposito, Roberto William Invernizzi, Matthew I. Palmatier, Rick A. Bevins, Francis C. Colpaert, Francis C. Colpaert, Craig A. Erickson, David J. Posey, Kelly Blankenship, Kimberly A. Stigler, Christopher J. McDougle, Mark Slifstein, Giovanni Hernandez, Peter Shizgal, Michael J. Kuhar, Tomek J. Banasikowski, Richard J. Beninger, Sara Tomlinson, Glen B. Baker, Stephen C. Fowler, Peter J. Flor, Inga D. Neumann, Joseph H. Friedman, Britta Hahn, Bernard Le Foll, Grasielle C. Kincheski, Leandro J. Bertoglio, Antonio Pádua Carobrez, Suzanne H. Mitchell, Harriet de Wit, Marie-Louise G. Wadenberg, Marlene Dobkin de Rios, Charles S. Grob, Theodora Duka, Linda Lundström, Silvia Gatti McArthur, Will Spooren, Peter J. Flor, Inga D. Neumann, Trevor W. Robbins, Jos Prickaerts, Harriet de Wit, Harriet de Wit, Peter H. Boeijinga, Yavin Shaham, Sunila G. Nair   +116 more
openaire   +1 more source

Rapamycin passes the torch: a new generation of mTOR inhibitors

Nature Reviews Drug Discovery, 2011
Michael N Hall
exaly  

Rapamycin.

Clinical and experimental rheumatology, 1993
R P, Carlson, S N, Sehgal, A J, Lewis
openaire   +1 more source